NASDAQ: GHRS - GH Research PLC

Yield per half year: -40.22%
Sector: Healthcare

GH Research PLC

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 48.77 -100% -77.25 -100%
P/S 0 33.76 -100%
P/BV 1.3 4.82 -72.97%
P/FCF 0 61 -100%
Ev/Ebitda -5.09 -22.15 -77.04%
Ev/S 0 22.56 -100%
Ev/FCF -6.22 68.78 -109.05%
E/P 0 0.0178 -100%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
0 4.98 -100% 0 0%
ROE -16.25 9.61 -269.09%
ROA -15.73 0.3443 -4667.95%
ROIC 0 7.63 -100%
ROS 0 -25.17 -100%
ROCE -18.77 15.35 -222.28%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.0084 -3.68 -99.77% -0.0135 -37.79%
Nеt Debt/Ebitda 1.91 -3.44 -155.54%
Debt/Ratio 0.0015 0.1985 -99.24%
Debt/Equity 0 1.66 -100%
Debt/Net Income -0.0096 10.32 -100.09%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5442 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0 0.2237 -100%
Average dividend growth 0 0.9889 -100%
Average percentage for 5 years 0 0.4952 -100%
Average percentage for payments 0 43.56 -100%
Difference from average difference in sector -0.5442

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
0 -56.89 -100%
Growth impulse Ebitda in 5 years 13175.16 -54.68 -24195.03%
Growth impulse Net Income in 5 years 11379.68 -58.33 -19609.14%
Growth impulse FCF in 5 years 11469.55 -49.48 -23280.17%
Growth impulse EPS in 5 years 6062.78 -32.41 -18806.51%
IP Score
4.16/10

Similar companies

Alexion

Amgen

ABIOMED

Gilead Sciences

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription